Maynard Um
-
-
-
-
-
-
-
Immuneering Corporation (IMRX) PT Lowered to $12; Piper Sandler: 'We Remain Buyers'
-
-
-
-
-
-
-
Mizuho Reiterates Outperform Rating on Immuneering Corporation (IMRX)
-
-
-
-
-
-
-
Mizuho Reiterates Outperform Rating on Immuneering Corporation (IMRX)
-
-
-
-
-
-
-
Immuneering Corporation (IMRX) Appoints Igor Matushansky as Chief Medical Officer
-
-
-
-
-
-
-
Immuneering Corporation (IMRX) Granted Orphan Drug Designation for IMM-1-104
-
-
-
-
396,355 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

